Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q2 2023 Home Health & Hospice Update

Skip to the end of the Expertise Menu

Q2 2023 Home Health & Hospice Update

Home health and hospice continue to play a pivotal role in payors’ value-based care strategies. Building on the successful completion of UHC’s acquisition of LHC Group earlier this year, the company has now set its sights on acquiring Amedisys in a landmark deal. This pending transaction follows the previously disclosed merger between Option Care Health and Amedisys. Following this announcement, a lead investor in Enhabit Inc. expressed interest to explore strategic alternatives, including exploring a sale. On the regulatory side, CMS continues to exert downward pressure on reimbursement. This June, CMS unveiled its FY 2024 proposed payment rule that includes a 2.2% decrease in aggregate home health payments. The proposed rule has garnered significant backlash from the market, including a federal lawsuit by The National Association for Home Care and Hospice.

To print and download the full Home Health & Hospice Update report, please click below…

[holo_button icon=”/wp-content/uploads/2023/07/Q2-2023-Newsletter-Package_Home-Health-Hospice.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]